tirzepatide surpass cvot In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. Full SURPASS-CVOT trial results: https://nej.md/4qd5rLx Flow of Participants in the

This process is called titration and it exists to give your body time to adjust, which helps reduce side effects like nausea and stomach discomfort

This design choice introduces potential bias, particularly for subjective outcomes, but it reflects the practical reality that these treatments have different injection devices and titration schedules that would make blinding extremely difficult

Dosages may be increased after your first 4 weeks

Lifting weights or doing resistance exercises applies force to your bones, which stimulates bone-building activity

The genetic test examines 150+ molecular insights across weight-loss pathways, allowing PlexusDx clinicians to recommend starting doses and escalation schedules matched to your genetic architecture rather than trial-and-error dosing